Home Newswires
USHealthVest in Big Indianapolis Center New Build PDF   E-mail
Addiction Treatment Industry Newswire

10/18/2018 -ATIN- US Healthvest, which has extensive addiction and mental health assets in the Chicago metro market, has announced an alliance with Indianapolis med surg Hendricks Regional to build a new stand alone $25M integrated behavioral health center.

Behind USHealthVest is Richard Kresch, a well known behavioral health entrepreneur who is the founder of Ascend Health Corporation, a closely held concern that is among the nation's largest specialty operators of integrated psychiatric and addiction centers. In March, US Healthvest bought Vista Medical Center West, now renamed Lake Behavioral Health, in north suburban Chicago from Quorum Health Corporation. Lake Behavioral Health is expected to expand to 100 beds from 46 currently.

The new Indianapolis facility, to be called Indianapolis Behavioral Hospital, will be a 77K sf integrated psychiatric/addiction treatment center and is expected to open in early 2020, creating approximately 250 new jobs.

Another man who was instrumental in building Ascend, former Goldman Sachs banker Steve Page, is behind NJ-based Sun Behavioral Health, which just last week opened a $25M integrated psych/addiction new build facility in Delaware.

READ OUR STORY on how big Wall Street money is backing integrated psych/addiction center new builds.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

New York Investor Group Buys Kansas Addiction Center PDF   E-mail
Addiction Treatment Industry Newswire
10/16/2018 -ATIN- A New York investor group has acquired Sunflower Wellness Retreat, a 23-bed addiction treatment center located about an hour southwest of Kansas City.

"We looked at a lot of different addiction treatment center models once we decided to focus on the addiction treatment business," says Lawrence Weiss, principal at Sunflower, one of three investors that this summer got together and purchased the center.

The trio decided, after closely examining a facility near San Francisco, against getting into the high-end private pay side of the treatment business, specifically citing the risk of soaring  marketing expense associated with client acquisition as well as intense competition due to the proliferation of "six-bed model" centers throughout California. There are now over 2,000 such centers in the state.

What attracted Weiss and partners to Sunflower was its deep referral relationships in the local community surrounding the center. "Sunflower is not a destination treatment experience," says Weiss. "We get all our clients from a 90 mile radius."

From a clinical effectiveness standpoint, Weiss points out that focusing on local clientele makes for ease of participation by families in the treatment of their loved ones. Strong family participation in the treatment experience correlates highly with outcomes success, research has shown.

Weiss and partners are far from the only investors who have sought to chip away at the dominance of national treatment "hubs" in Florida, Arizona and California, states that are overflowing with "destination" addiction centers.

Philadelphia real estate developer Brian O'Neill founded Recovery Centers of America with a local catchment model of client acquisition in mind. He has bought centers and upgraded them and done greenfield new builds as well as property conversions, mostly in the middle Atlantic states and the Northeast.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Gateway Corrections Sees Big Jump in Community Treatment Contracts PDF   E-mail
Addiction Treatment Industry Newswire

10/13/2018 -ATIN- Gateway Chicago's corrections addiction treatment division, the second largest corrections provider in the nation, is seeing a big move away from in-prison treatment contracts toward community based treatment of offenders.

"There is a major trend, which in one form or another is happening in virtually every state, to move corrections treatment out of jails and prisons and into the community," says Gregg Dockins, president of Gateway's corrections unit.

He says that 50 percent of Gateway Corrections' expected $43M in revenue this year will come from community-based contracts, up from just 5 percent a couple of years ago.

Gateway Chicago CEO Tom Britton says he expects overall Gateway revenues, which include its big consumer business, driven by revenue from commercial payors, to reach $135M this year, up from $112M the year ended June 30. Gateway's consumer side is largely focused on Illinois, where it is by far the largest player with 14 centers, but Britton has been pursuing an M&A growth strategy and has been targeting acquisitions in at least four states.

One feature of the community based treatment contracts, and one Dockins expects to be a significant source of growth going forward, is that county and state governments are widening the scope of services they are contracting out to providers like Gateway.

"In a significant number of cases we are not just being hired to run the treatment side, but are also responsible for the overall management of offenders, which typically in the past was handled by probation officers and the like," says Dockins.

The nation's largest corrections treatment provider, by far, is the big private corrections contractor GEO Corrections, based in South Florida. The GEO Care division, which Gateway competes with, comprises GEO's privatized mental-health and residential-treatment services business. Last year, GEO paid $360M for Community Education Centers, CEC, which was previously the second largest corrections addiction treatment provider. Westcare of Las Vegas is also a significant player in corrections care.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Banyon Buys Sunspire's Heartland Illinois Addiction Center PDF   E-mail

10/08/2018 -ATIN- Florida's Banyon Treatment Centers, one of the most aggressively expanding specialty addiction providers in the nation, has reportedly purchased Sunspire Health's Heartland center, a now defunct facility that Banyon may be planning  to resurrect.

A well placed source from Chicago, which is about 60 miles from the Heartland property, says Banyon is actively seeking to fill an executive director position for Heartland, but Banyon executives were not immediately available for comment.

Sunspire Health was sold by its founder, Ben Klein, a couple of years ago to prestigious private equity firm Kohlberg & Co. Klein has recently taken control of addiction treatment giant Elements Behavioral Health through a bankruptcy auction and plans to take the CEO slot when the deal is given final approval by a federal judge. After buying Sunspire, Kohlberg paid big bucks for the world famous Arizona center The Meadows, which was one of the first addiction treatment industry forays by a private equity investor fifteen years ago.

Since the Sunspire buy, Kohlberg has been trimming its assets shutting down a facility in the Northwest and now apparently offloading the Heartland property. A treatment center CEO in Chicago who was pitched as a possible buyer said Heartland was quite rundown and in need of significant investment.

Banyon has an outpatient center in Chicago, so Heartland will presumably allow Banyon to serve the nation's second largest metro market with a broader continuum of care.

Banyon Buys BHOPB

Earlier this year, Banyon made one of the biggest deals in the specialty addiction marketplace by buying struggling Behavioral Health of the Palm Beaches, BHOPB, which had about 200 beds but was imploding under CEO and co-founder Jack Coscia. BHOPB began bleeding staff, which were hired by centers like The Florida House, among others. At one time, under the astute management of treatment exec Alan Stevens, BHOPB was a thriving center whose properties were arguably the best in the huge South Florida hub and whose cutting edge clinical models were widely admired and emulated.

What reportedly brought BHOPB down was a botched takeover deal, allegedly epicly mishandled. About three years ago a Colorado private equity firm approached BHOPB and, sources say, offered about $130M for the provider, which if the deal went through would have been one of the largest transactions in addiction treatment history. Instead, sources say, BHOPB held out for more money, a source says just $3M. The Colorado private equity buyer, allegedly frustrated, walked away from the deal.

Banyon has also bought the Clearview center in Pennsylvania, and has opened a detox and residential property in Boca Raton. The only two BHOPB properties currently in operation under Banyon are a big center in western Palm Beach county, a motel conversion adroitly pulled off by Coscia, and the Seaside Palm Beach property just accross from the beach in Palm Beach Shores, one of the most valuable addiction properties in the nation.

Jack Coscia and Banyon operations chief Eric Oakes did not immediately respond to requests for comments.

READ OUR Special Report on Banyon's unique BHOPB Seaside Palm Beach property

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Charleston Naval Base in Residential Addiction Center Conversion PDF   E-mail
10/06/2016 -ATIN - Meridian Behavioral Health Systems, a for-profit with an eclectic mix of assets in five states, has bought a former naval information base in Charleston and is converting the 123-acre property into a specialty addiction center.

The new facility, which will have 95 beds, was bought in an auction held by the General Services Administration. Alabama-based Mellivora Capital Partners won the auction in December in 2016..

In February, Meridian Behavioral Health Systems, of which Charleston's Highland Hospital behavioral health facility is a subsidiary, announced that it had leased the base for use as a residential rehab center and planned to open in July.

The opening was pushed back to October and is now indefinite. Construction is needed to bring a base dormitory building's roof, kitchen and therapeutic areas up to regulatory standards.

The new addiction rehab is expected to employ 200 people.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

READ OUR STORY on Sun Behavioral's new facility

Suboxone Still Delivering Huge Profit Margins  E-mail
10/04/2018 -ATIN- Buprenorphine pioneer Invidior, a british pharma whose sole focus is addiction MAT therapies, is still pumping out huge profit margins on its core Suboxone branded medication, although generics competition has cut the drug's sales in half since 2012.

Last week, Invidior said it expects Suboxone sales of approximately $1B in its 2018 fiscal year with an eye popping net profit margin of 25%, or $250M.  The fat margins allowed Invidior to pay down $150M of debt earlier this year.

Invidior's bup strategy is twofold. On the one hand the company is aggressively pursuing patent infringement suits in Federal court against generic competition, while at the same time also pursuing the vintage pharma "old wine in a new bottle" sleight-of-hand.

Invidior this summer got a preliminary injunction barring New Jersey-based Dr. Reddy's Laboratories from selling its bup/naloxone generic. And the company is rolling out its Sublocade branded therapy. Sublocade is Suboxone delivered in a monthly injection format, which allows Invidior to charge far more because the drug operates under a new patent, thus "old wine in a new bottle."

Another pharma, Alkermes, pursued that same strategy when it put generic naltrexone in a monthly injection and called it Vivitrol, whose sales have been turbocharged of late as the opiate crisis has opened huge state, federal and private insurance funding for MAT therapies. President Trump is expected to sign a bill this month that allocates billions to the fight against opiate use disorder.

There is little doubt that Invidior will also be attempting to tap into the opiate funding wave with Sublocade. Though early results are disappointing. Last week Invidior lowered its sales expectations for Sublocade in 2018 to at most $10M, down from the previous estimate of $25M.

The advertised cash pay price for Sublocade is a staggering $18K, a price on which Individior will very likely offer large discounts. Still, the cost of generic Suboxone is now a few hundred dollars a month.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Sun Behavioral In $25M New Build Treatment Facility  E-mail
10/02/2018 -ATIN- Sun Behavioral, an integrated mental health and addiction treatment provider, has just opened a $25M new build center on a six-acre campus in Georgetown, DE. The new facility will employ approximately 150 people.

New Jersey-based Sun Behavioral has similar facilities in Kentucky, Texas and and Ohio.

The company's CEO, Steve Page, is a former Goldman Sachs healthcare and M&A banker who was instrumental in building Ascend Health Corporation into one of the nation's largest behavioral health concerns.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

READ OUR STORY on how Wall Street money is backing new build, behavioral healthcare facilities nationwide

SAMHSA Doling Out Big Bucks to States  E-mail
10/02/2018 -ATIN- SAMHSA has lately begun to dole out big bucks to the states, with Ohio just one state that late last month was the recipient of big grant earmarks. Ohio, among the very hardest hit  by the addiction crisis, will get $71M to aid a medication-assisted treatment push, as well as substantial funds earmarked for treatment in underserved rural areas.

And more money can be expected in the upcoming federal fiscal year, which begins in the fall, as Congress prepares to send an $8B special opiate appropriation bill to President Trump for his signature. While the appropriation does boost spending by about $3B, much of the money goes toward law enforcement and critics say it falls far short of other previous epidemic crisis responses, for example the $100B spent combating aids.

And the money is being spent in Ohio as the state gears up for a controversial ballot measure that would eliminate felony punishment for all types of drug possession, with the measure being retroactive. Liberal billionaires like George Soros, Mark Zuckerberg and Susan Pritzker have poured money into backing the initiative, which would put about 10,000 people currently jailed back onto the street again, significantly emptying state prisons. Money saved from the prison expenditures would go toward treatment.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Orange County DA Hands Down Addiction Treatment Indictments  E-mail
09/30/2018 -ATIN- An Orange County DA has brought down a raft of charges against more than a dozen people alleging misconduct ranging from performing unnecessary medical procedures to patient brokering.

Particularly targeted were a group of doctors and outreach marketers that allegedly rounded up clients for expensive - $40K per procedure - naltrexone implant surgery, targeting those with good health insurance and offering kickbacks.

The charges are serious, carrying sentences of 10 yrs to 40 yrs, and come on the heels of vigorous prosecutions of addiction treatment industry wrongdoing in other parts of the country, particularly in Florida.

Orange County, like the rest of Southern California, has been the scene of an enormous increase in the number of addiction treatment and sober living centers, facilities that are only very loosely regulated. That situation is changing radically after Governor Jerry Brown last week signed into law a group of bills designed to rein in unscrupulous behavior and create basic common standards of addiction care.

The roots of the Southern California "Rehab Riviera" can be found in 1970s legislation creating the "six bed" model of care. Designed to end the warehousing of mentally ill patients in big, institutional settings, the law prohibited municipal jurisdictions from denying zoning permission for mental health facilities of six beds or less.

In the 1990s, Promises Malibu was the first high end addiction center to apply the legislation to the treatment industry and to luxury addiction care. Since then over 2,000 treatment centers have sprung up all over the state, making it a rival for Florida as the nation's biggest addiction treatment "hub."

In Southern California, the epicenter of the Rehab Riviera is in Newport Beach, residents of which have risen up in virulent NIMBY - not-in-my-backyard - reactions to the proliferation of addiction treatment centers.


READ OUR story on recent California addiction treatment regulatory legislation

READ OUR Special Report on the development of California's "six bed model" of addiction treatment

Gateway Chicago Opens Big New Illinois Center  E-mail
09/28/2018 -ATIN- Chicago's Gateway Foundation, one of the biggest non-profit addiction treatment enterprises nationwide with $115M in annual revenue, this week opened its fifteenth center in illinois, a state in which Gateway is by far the largest addiction treatment provider.

Gateway bought the former Wells Center site in downstate Jacksonville, IL earlier this year after that facility closed in 2017. Subsequent renovations gave the old facility a face lift. The center offers a full continuum of care, including aftercare sober living services.

Gateway derives 65 percent of its revenues from Illinois and also is among the largest corrections treatment providers, with prison operations in six states.

CEO Tom Britton, who took over from founding CEO Michael Darcy in 2015, previously ran the youth and wellness divisions at addiction treatment giant Acadia Healthcare.

Rosecrance, whose main campus is in Rockford, IL, has also opened a new facility in downstate Illinois this year and in recent years has been expanding aggressively, opening new centers on Chicago's North Side.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Andrea Barthwell Named to Oversee Huge New Opiate Non-Profit  E-mail

09/26/2018 - ATIN- Renowned addiction treatment executive Andrea Barthwell has been named to a prestigious newly created post overseeing the non-profit foundation recently formed by medical services giant McKesson Corp., which has set the initial funding of the addiction charitable enterprise at a hefty $100M.

Also appointed to a top post at the Foundation for Opioid Response Efforts (FORE) is Karen Scott, who will fill the job of a hands on manager as president. Dr. Barthwell will be board chair.

Both women have had distinguished healthcare careers, where Barthwell is a former deputy Drug Czar for treatment, while Dr. Scott is well known for her work at global health care consultancy Health Management Associates.

In March McKesson, among the very largest healthcare concerns worldwide with $200B in annual sales, announced the formation of the opiate fund. Dr. Barthwell and Dr. Scott will have the immediate and very important task of setting spending priorities and mission goals for FORE.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Oxford Hires Former Mississippi Drug Czar as Clinical Director  E-mail
09/26/2018 - ATIN- Oxford Treatment, one of Mississippi's largest addiction centers, has hired the former chief of the state drug and alcohol agency as its new clinical director.

Jerri Avery has more than 20 years experience including most recently as director of Acadia Healthcare's Jackson facility.

Ms. Avery's intention is to hire a cadre of new therapists at Oxford, according to a statement.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Origins Hires New Marketing Chief  E-mail
09/25/2018 -ATIN- Origins Behavioral Healthcare has named a new marketing chief, a move that comes on the heels of this summer's announcement that the center, with assets in Florida and Texas, had appointed a new, permanent CEO. In one of the biggest addiction treatment deals in recent years, Origins was sold in 2017 by its founding owners, the Levenson family of Texas, to the billionaire Rowling family, also of Texas.

Glenn Gill, a marketer with a resume that includes the world famous Leo Burnett ad agency as well as Square One Advertising, has taken up the task of running marketing at Origins. In late July, the Rowling family appointed one of their very top, longtime lieutenants, Jim Caldwell, as CEO of Origins. Caldwell took over from Robert Rowling, Jr., a scion of the Rowling family whose "first love" is being a practicing therapist, the pursuit of which Rowling, Jr. has now returned to while retaining a governance role at Origins as board chairman.

Origins was sold in May 2017 to TRT Holdings, the Rowling holding company whose operating assets include such household names as Omni Hotels and Gold's Gym. Caldwell has served as a top TRT executive for three decades.

After being founded in 2009 by the Levensons, also a highly entrepreneurial Texas clan with interests in oil and restaurants, Origins has emerged as a national treatment brand. The company acquired perennial money losing Hanley Center of West Palm Beach, FL, in late 2014. The Levenson family will remain influential in the behavioral health arena through their control of the Levenson Foundation and MAP Health Management, an outcomes measurement and aftercare outsourcer run by Jacob Levenson.

Well known treatment exec Drew Rothermel was Origins CEO for years under the Levensons. Rothermel recently has taken on the key role of managing private equity investor Fulcrum Equity Partners' foray into addiction treatment. Rothermel has overseen the acquisition of centers in Florida and Pennsylvania this year.

Rothermel just last week announced the creation of City Line Behavioral, a holding company for Fulcrum's treatment assets. City Line has a hired a rock star line up of treatment execs, including former Sierra Tucson CEO Keith Arnold as marketing chief. Rothermel is CEO.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

MAT Addiction Centers Begin to Push Monthly Buprenorphine Injection  E-mail
09/25/2018 - ATIN- Despite the fact that buprenorphine is by far the best selling medication-assisted-therapy, MAT, and the fact that the compound should be dirt cheap - it's been generic for decades - many companies keep buprenorphine MAT therapy prices high by tweaking drug formulas and getting new patents.
One such effort is being successfully deployed by the successor company to Suboxone maker Reckitt Benckiser Pharmaceuticals. Reckitt Benckiser, a European concern which makes most of its revenue from household products like Lysol, spun off it's pharmaceutical subsidiary into a separately traded entity that is now called Invidior (London: INDV). Earlier this year, Invidior got FDA approval for a monthly buprenorphine injection - brand name Sublocade - that the company is marketing aggressively.

In Indiana, a MAT-based outpatient center, called Lucina Treatment Center, is making Sublocade a centerpiece therapy. Lucina is the first center in the Midwest to offer Sublocade.

While it's not known how much health insurers will be paying for Sublocade, health insurance deals are always secret, Invidior is marketing the cash pay rate for Sublocade at $18K per monthly shot. And given that states like Illinois have passed opiate crisis laws mandating that Medicaid and private insurers take away all barriers to addiction MAT therapies, it seems likely that Sublocade could make substantial inroads. Certainly Invidior is hoping that Sublocade sales will mitigate a slowdown in Suboxone revenue.

Suboxone sales peaked at slightly less than $2B at an annualized rate in the fourth quarter of 2012, making the drug one of the biggest blockbusters in pharmaceutical industry history. Suboxone sales are still huge, running at about $1B a year. Generic versions of Suboxone are offered by a number of drug makers, but costs are still high to the consumer.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

ACLU Sues Massachusetts Sheriff Over Prisoner Access to MAT  E-mail

09/24/2018 -ATIN- The Massachusetts arm of the American Civil Liberties Union is suing a county sheriff, alleging that prisoners in a local jail are denied access to medication assisted therapies (MAT). While the  Essex County jail does offer Vivitrol, the county does not allow those on Suboxone or methadone to continue their treatment while incarcerated.

Essex County Sherrif Kevin Coppinger says that while the Middleton, MA jail does offer a variety of addiction treatment programs for county inmates, methadone and Suboxone treatments are not allowed due the potential for abuse and diversion.

The ACLU is suing on behalf of a man who faces county time due to a traffic violation. The man is on methadone maintenance and has been denied methadone since being incarcerated. Withdrawl from methadone and other synthetic opiates like buprenorphine, the active ingredient in Suboxone, is signficantly more difficult and risky to one's health than withdrawl from natural opiates like morphine or heroin.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

$25M Tribal Center New Build in North Dakota  E-mail

09/23/2018 -ATIN- The Mandan, Hidatsa and Arikara tribes of North Dakota, collectively known as the Three Affiliated Tribes, have opened a $25M new build addiction treatment facility in Bismark. In general, native indians typically require addiction treatment in greater demographic proportion than the overall US population.

The Good Road Recovery Center is a 20K+ sf center with 5 buildings on a multi-acre campus with residential capacity of 16, as well substantial capacity for outpatient care. The center will employ 40.

Over the past three years, Three Affiliated Tribes has been sending tribal members out-of-state for drug and alcohol addiction treatment. On average, three to four tribal members each week are being sent to these facilities..

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Facebook, Instagram Drug Seekers Pushed Toward Treatment  E-mail

09/23/2018 -ATIN- Drug dealing is rampant on social media platforms, but popular sites like Instagram and Facebook are fighting back with pop ups that offer help for addiction whenever popular searches like "fentanyl" or "uppers" are queried." The pop ups ask those seeking drugs on the social media platforms if they wouldn't rather get some help for their addiction instead.

Social Media concerns have also permanently taken down certain hashtags or handles like #fentanyl or #xanax, making them unsearchable. But for most people seeking drugs online these actions represent just a speed bump since small modifications like #fentanyls or #xanaxs are still searchable and thousands of online dealers are routinely able to get around whatever barriers to dealing are being put up by social network companies.

Instagram puts up a notice asking whether or not someone might need help with a opioid problem, also making a link to SAMHSA's website available.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

California's Sunshine Behavioral in Colorado Hotel Conversion  E-mail

09/21/2018 -ATIN- Southern California-based Sunshine Behavioral Health is looking to convert a Ramada Inn into a residential addiction treatment center in the town of Monument, CO, which is located near Colorado Springs. Sunshine Behavioral paid $4M for the hotel property.

While the hotel property is already zoned to accommodate a treatment center, Monument residents are nevertheless gearing up for a NIMBY (not-in-my-back-yard) campaign opposing the redevelopment. In 2016, the city of Monument paid methadone clinic giant Colonial Management Group $900K in exchange for agreeing not to locate a clinic in the town.

Some residents are jumping on the fact that Sunshine Behavioral was one of eight treatment providers that were subpoenaed by a congressional committee this summer to provide documents  for a "body broking" inquiry into the addiction treatment industry.

If the county rejected the project based on a reason outside the scope of the site plan, it could find itself in court over alleged violations of federal fair housing laws. There are few, if any, cases that have been won in federal court by municipalities seeking to bar addiction center development.

Texas Center Caters to Sex Addicted Priests  E-mail
09/21/2018 -ATIN- In 1947 the U.S. Catholic Church opened the first of its treatment centers dedicated to caring for priests with sex and substance addictions, including pedophelia. And now the Shalom Center near Houston has been raided by local police and units of the Texas Rangers seeking information on a priest, Manuel La Rosa Lopez, who was treated over 15 years ago and is now accused of abusing young parishioners.

The Shalom Center's website states, "We genuinely seek to create a spirit of Gospel compassion, a nonjudgmental atmosphere and a safe environment where healing and growth can happen."

According to the Houston Press, the Shalom Center is included in a 1995 U.S. Conference of Bishops survey on treatment centers, in which it's described as dealing mostly with priests suffering from "behaviors related to pornography, sexual exploitation, exhibitionism, voyeurism, and prostitution." The survey, available on the Bishop Accountability website, notes that initial assessments and referrals are available for priests dealing with "pedophilia and ephebophilia [sexual attraction to adolescents]."

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

US Senate in Key Opiate Bill, Legislation Awaits CA Gov Signature  E-mail
09/20/2018 - ATIN- The U.S. Senate, in a bipartisan effort, has passed comprehensive legislation aimed at addressing the opiate crisis, providing almost $8B in a special funding appropriation for the legislation, a version of which was passed by the house in June. Final legislation that reconciles the two bills is expected shortly, ready for President Trump's signature next month.

Numerous senators have spoken out on the seriousness of the opiate epidemic, with the CDC estimating in the last several weeks that nearly 72K died of drug overdoses in the 12 months ending March 2017, up from 62K a year earlier.

The federal opiate addiction effort will focus to a large extent on law enforcement and "interdiction," focusing especially on intercepting dangerous supplies the ultra powerful synthetic opiate fentanyl.

Just $10M in funding will go to establishing "comprehensive" addiction treatment centers starting 2019. The federal legislation encourages medication-based therapies which often are not offered a treatment centers


There are three separate pieces of legislation sitting on the governor of California's desk. The legislation is particularly important  for  the treatment industry given that Southern California is a major treatment "hub," second only the South Florida, which recently passed significant legislation regulating the treatment and sober living industries in the state.

For example, patient broking, which is rampant in the treatment business, was made a felony last year in legislation that sailed through both houses in Florida.

Here are the bills awaiting the California governor's signature:

AB 3162, which would make rehab licenses provisional for one year and revocable for good cause.

SB 992, which would require centers to draft plans for what to do when residents relapse, as well as require that financial relationships between sober living homes and licensed treatment centers are publicly disclosed.

And SB 1228 which would forbid patient-brokering (no criminal penalties)

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Hazelden Betty Ford in New Seattle Outpatient Center  E-mail

09/19/2018 -ATIN- Hazelden Betty Ford, the world famous center based in Minnesota, is planning to open an intensive outpatient facility in the Seattle area, it's fifteenth clinical center. Opening is slated for early 2019.

Shortly after the historic merger of Palm Springs-based Betty Ford with Hazelden in late 2013, CEO Mark Mishek unveiled plans for an aggressive nationwide rollout of outpatient clinics, the latest example of which is the new Seattle area center.

Hazelden Betty Ford has in fact not been at all aggressive about the rollout, with just a few centers opening since 2014.The new Seattle area outpatient facility -to be named Hazelden Betty Ford in Bellevue- will  employ eight people initially.

"We heard from a number of Seattle-area business and healthcare leaders, who said additional quality treatment services were needed to meet swelling demand brought on by the opioid overdose epidemic and broader addiction crisis," said Mishek. "The local leaders who invited us into the area identified a specific need for medication-assisted treatment services to help individuals and families affected by opioid addiction," Mishek said.

Hazelden will be offering a therapeutic regimen it calls Comprehensive Opioid Response with the Twelve Steps, or COR-12, a trade marked treatment methodology.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

READ OUR Special Report on Hazelden Betty Ford

Page 1 of 25

Recent Print Issue: Sept 2015 | Subscribe Now!

Special Report
Austin's MAP Looking to Future
andValue-Based Compensation
Growth Through Licensing

On the Cover: Jacob Levinson
Founder, CEO MAP

Click here to read the digital
print edition of TM.

Follow Treatment Magazine on Twitter!
Become a fan of Treatment Magazine on Facebook!